152 results on '"Gianolio E"'
Search Results
2. B25716/1: a novel albumin-binding Gd-AAZTA MRI contrast agent with improved properties in tumor imaging
3. High sensitivity lanthanide(III) based probes for MR-medical imaging
4. Ternary Gd(III)L-HSA adducts: evidence for the replacement of inner-sphere water molecules by coordinating groups of the protein. Implications for the design of contrast agents for MRI
5. Absence of dentate nucleus resting-state functional connectivity changes in nonneurological patients with gadolinium-related hyperintensity on T1 -weighted images
6. Ap(O2)-Responsive MRI Contrast Agent Based on the Redox Switch of Manganese(II /III) – Porphyrin Complexes
7. PEPTIDES CONJUGATES, THEIR DERIVATIVES WITH METAL COMPLEXES AND USE THEREOF FOR MAGNETIC RESONANCE IMAGING (MRI)
8. Controlled mixing of lanthanide(III) ions in coacervate
9. New Peptide conjugates as ligand for cholecystokinin receptor
10. Photochemical activation of endosomal escape of MRI-Gd-agents in tumor cells
11. Solution structure of the supramolecular adduct between a liver cytosolic bile acid binding protein and a bile acid-based gadolinium(III)-chelate, a potential hepatospecific magnetic resonance imaging contrast agent
12. NMR structural studies of the supramolecular adducts between a liver cytosolic bile acid binding protein and Gd(III)-chelates bearing bile acids residues: molecular determinants of the binding of hepatospecific MRI contrast agent
13. NMR characterization of the interaction between a bile acid binding protein and a novel cholate-based analogue of a Gd(III) complex designed as a potential specific contrast agent for MRI
14. IMPROVED SYNTHESES OF BIS( -CYCLODEXTRIN) DERIVATIVES, NEW CARRIERS FOR GADOLINIUM COMPLEXES
15. New insights for pursuing high relaxivity MRI agents from modeling the binding interaction of Gd(III) chelates to HAS
16. [Gd-AAZTA]-: A New Structural Entry for an Improved Generation of MRI Contrast Agents
17. High Relaxivity Contrast Agents for MRI and Molecular Imaging
18. Modulation of the prototropic exchange rate at the water molecule coordinated to a Gd-III ion
19. DESIGNING NOVEL CONTRAST AGENTS FOR MAGNETING RESONANCE IMAGING. SYNTHESIS AND RELAXOMETRIC CHARACTERIZATION OF THREE GADOLINIUM (III) COMPLEXES BASED ON FUNCTIONALIZED PYRIDINE-CONTAINING MACROCYCLIC LIGAND
20. β-Cyclodextrin adducts of Gd(III) chelates: useful models for investigating the structural and dynamic determinants of the relaxivity of gadolinium-based systems
21. Highly luminescent Eu3+ and Tb3+ macrocyclic complexes bearing an appended phenanthroline chromophore
22. Synthesis and characterization of new MRI contrast agents
23. Highly Luminescent Eu(III) and Tb(III) Macrocyclic Complexes Bearing an Appended Phenanthroline Chromophore
24. Modulation of the water exchange rate in Gd(III) complexes
25. Relaxometric Investigations and MRI Evaluation of a Liposome-Loaded pH-Responsive Gadolinium(III) Complex
26. Advances in Metal-Based Probes for MR Molecular Imaging Applications
27. CMR2009: 5.09: B25716/1: a novel Gd-AAZTA-based MRI agent with albumin binding properties
28. NMR solution structure of the supramolecular adduct between a liver cytosolic bile acid binding protein and a bile acid-based Gd(III)-chelate
29. Targeting Cells with MR Imaging Probes Based on Paramagnetic Gd(III) Chelates
30. High Relaxivity Contrast Agents for MRI and Molecular Imaging.
31. Heat Transfer Coefficients and Pressure Drops for Air Coolers with Different Numbers of Rows Under Induced and Forced Draft.
32. Mannich Reaction as a New Route to Pyridine-Based Polyaminocarboxylic Ligands
33. High relaxivity contrast agents for MRI and molecular imaging
34. Peptide-based soft hydrogels modified with gadolinium complexes as MRI contrast agents
35. Peptide-based building blocks as structural elements for supramolecular Gd-containing MRI contrast agents
36. Micelles Obtained by Aggregation of Gemini Surfactants Containing the CCK8 Peptide and a Gadolinium Complex
37. Release of toxic Gd3+ ions to tumour cells by vitamin B12 bioconjugates
38. Micelles derivatized with octreotide as potential target-selective contrast agents in MRI
39. Supramolecular aggregates as selective and high relaxivity contrast agents in MRI
40. Peptide derivatized liposomes as target specific MRI contrast agents
41. Multicomponent aggregates containing the CCK8 Bioactive peptide and Gd complexes as target-specific MRI contrast agents
42. Physicochemical properties of mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI
43. Characterization of a multicomponent aggregate containing a bio-active peptide and a Gd complex
44. Subcutaneous Administration of a Zwitterionic Chitosan-Based Hydrogel for Controlled Spatiotemporal Release of Monoclonal Antibodies.
45. The role of gadolinium-based contrast agents in magnetic resonance imaging structured reporting and data systems (RADS).
46. Seeking for Innovation with Magnetic Resonance Imaging Paramagnetic Contrast Agents: Relaxation Enhancement via Weak and Dynamic Electrostatic Interactions with Positively Charged Groups on Endogenous Macromolecules.
47. Skin Toxicity After Exposure to Gadolinium-Based Contrast Agents in Normal Renal Function, Using Clinical Approved Doses: Current Status of Preclinical and Clinical Studies.
48. Water-Soluble Chiral Cyclic Peptoids and Their Sodium and Gadolinium Complexes: Study of Conformational and Relaxometric Properties.
49. Comparison of the biological effects of gadodiamide (Omniscan) and gadoteridol (ProHance) by means of multi-organ and plasma metabolomics.
50. Incorporation of PEG Diacrylates (PEGDA) Generates Hybrid Fmoc-FF Hydrogel Matrices.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.